Cargando…

Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

BACKGROUND/AIMS: Breast cancer metastasis suppressor 1 (BRMS1) blocks metastasis in melanoma xenografts; however, its usefulness as a biomarker in human melanomas has not been widely studied. The goal was to measure BRMS1 expression in benign nevi, primary and metastatic melanomas and evaluate its i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slipicevic, Ana, Holm, Ruth, Emilsen, Elisabeth, Ree Rosnes, Anne Katrine, Welch, Danny R, Mælandsmo, Gunhild M, Flørenes, Vivi Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341185/ https://www.ncbi.nlm.nih.gov/pubmed/22356677 http://dx.doi.org/10.1186/1471-2407-12-73

Ejemplares similares

High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
por: Magnussen, Gry Irene, et al.
Publicado: (2012)

The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells
por: Slipicevic, Ana, et al.
Publicado: (2008)

Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma
por: Flørenes, Vivi Ann, et al.
Publicado: (2015)

Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma
por: Engesæter, Birgit, et al.
Publicado: (2012)

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma
por: Magnussen, Gry Irene, et al.
Publicado: (2015)

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma
por: Fleten, Karianne G, et al.
Publicado: (2016)

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases()
por: Flørenes, Vivi Ann, et al.
Publicado: (2019)

Soluble AXL as a marker of disease progression and survival in melanoma
por: Flem-Karlsen, Karine, et al.
Publicado: (2020)

AXL inhibition improves BRAF-targeted treatment in melanoma
por: Nyakas, Marta, et al.
Publicado: (2022)

Expression of the metastasis suppressor BRMS1 in uveal melanoma
por: Ventura, Bruna V, et al.
Publicado: (2014)

Location, location, location: the BRMS1 protein and melanoma progression
por: Riker, Adam I, et al.
Publicado: (2012)

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
por: Maelandsmo, G. M., et al.
Publicado: (1996)

Perturbation of BRMS1 interactome reveals pathways that impact metastasis
por: Zimmermann, Rosalyn C., et al.
Publicado: (2021)

High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients
por: Magnussen, Gry Irene, et al.
Publicado: (2013)

p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
por: Flem-Karlsen, Karine, et al.
Publicado: (2019)

Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
por: Wang, Zhihui, et al.
Publicado: (2010)

BRMS1 in Gliomas—An Expression Analysis
por: Feldheim, Jonas, et al.
Publicado: (2023)

Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation
por: Samant, Rajeev S, et al.
Publicado: (2007)

TP53 allele loss, mutations and expression in malignant melanoma.
por: Flørenes, V. A., et al.
Publicado: (1994)

The C-Terminal Putative Nuclear Localization Sequence of BReast cancer Metastasis Suppressor 1, BRMS1, Is Necessary for Metastasis Suppression
por: Hurst, Douglas R., et al.
Publicado: (2013)

Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma
por: Prasmickaite, Lina, et al.
Publicado: (2010)

Identification of Essential Sequences for Cellular Localization in BRMS1 Metastasis Suppressor
por: Rivera, José, et al.
Publicado: (2009)

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
por: Dillard, Pierre, et al.
Publicado: (2021)

BRMS1 Sensitizes Breast Cancer Cells to ATP-Induced Growth Suppression
por: Zhang, Yue, et al.
Publicado: (2013)

Narrowing the knowledge gaps for melanoma
por: Slipicevic, Ana, et al.
Publicado: (2012)

BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells
por: Mei, Pengjin, et al.
Publicado: (2014)

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

BRMS1 gene expression may be associated with clinico-pathological features of breast cancer
por: Lin, Li-Zhong, et al.
Publicado: (2017)

Identification of BRMS1L as Metastasis Suppressing Gene in Esophageal Squamous Cell Carcinoma
por: Zhou, Ruihao, et al.
Publicado: (2020)

Modelling and simulation of mutant alleles of breast cancer metastasis suppressor 1 (BRMS1) gene
por: Adeel, Muhammad Muzammal, et al.
Publicado: (2014)

Retraction: BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells
Publicado: (2022)

ERα Mediates Estrogen-Induced Expression of the Breast Cancer Metastasis Suppressor Gene BRMS1
por: Ma, Hongtao, et al.
Publicado: (2016)

Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53
por: Koyama, Ryota, et al.
Publicado: (2017)

MicroRNA-3200-5p Promotes Osteosarcoma Cell Invasion via Suppression of BRMS1
por: Li, Gen, et al.
Publicado: (2018)

Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines
por: Farokhimanesh, Samila, et al.
Publicado: (2020)

Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2020)

Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival
por: He, Qing-Mei, et al.
Publicado: (2012)

Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation
por: Huo, Xiongwei, et al.
Publicado: (2015)

Cystatin E/M suppresses legumain activity and invasion of human melanoma
por: Briggs, Jon J, et al.
Publicado: (2010)

N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1
por: Zhou, Chenliang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vvptdrvt3br258pu0oi1bsna2r